Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients

NCT02370979 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT02370979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients
Lead sponsor
University Hospital, Strasbourg, France
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
July 31, 2017
Enrollment
202 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection